NMC
NEA Management Company Portfolio holdings
AUM
$1.33B
This Quarter Return
+87.13%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$2.49B
AUM Growth
+$574M
(+30%)
Cap. Flow
-$375M
Cap. Flow
% of AUM
-15.07%
Top 10 Holdings %
Top 10 Hldgs %
64.37%
Holding
51
New
1
Increased
2
Reduced
3
Closed
5
Top Buys
| 1 |
AKUS
Akouos, Inc. Common Stock
AKUS
|
$96.7M |
| 2 |
Trevi Therapeutics
TRVI
|
$9.87M |
| 3 |
AVEO
AVEO Pharmaceuticals, Inc.
AVEO
|
$7.36M |
Top Sells
| 1 |
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
|
$295M |
| 2 |
Mersana Therapeutics
MRSN
|
$93.7M |
| 3 |
EPZM
Epizyme, Inc
EPZM
|
$67.9M |
| 4 |
Ardelyx
ARDX
|
$17.3M |
| 5 |
SURF
Surface Oncology, Inc. Common Stock
SURF
|
$6.2M |
Sector Composition
| 1 | Healthcare | 79.03% |
| 2 | Technology | 16.28% |
| 3 | Consumer Discretionary | 2.25% |
| 4 | Industrials | 0.58% |